Abstract
Inflammatory bowel diseases(IBD)includes ulcerative colitis (UC) and Crohn′s disease (CD). Recently, the incidence of IBD in China has been growing rapidly and caused a major public health burden. Although several traditional diagnostic methods can directly evaluate intestinal inflammation in patients with IBD, there are still limitations in these methods such as invasive or unreliable results because of clinical and pathologists′ clinical experience. Therefore, there is urgent need for non-invasive, objective and reliable tool for IBD diagnosis or monitoring.With the development of technology and understanding of the pathogenesis of IBD, much progress has been achieved to discover novel IBD biomarkers in genetic, microecological, metabolomics and gut barrier field. In this review, we will demonstrate current updates of IBD related biomarkers and showed future prospective of these biomarkers.(Chin J Lab Med, 2018, 41: 712-715) Key words: Inflammatory bowel diseases; Biomarkers
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
